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Objectives: Helicobacter pylori (Hp) is an important
human pathogen associated with gastrointestinal diseases
such as gastritis, peptic ulcer disease (PUD) and gastric can-
cer. A number of pathogenic factors have been described
for this bacterium, and some of them have been proposed
as predictive markers of the clinical outcomes. However,
with the exception of the cag and vacA status, there is no
global consensus regarding the role of the other introduced
virulence factors. Therefore, the aim of this study was to
investigate the status of Hp strains regarding the Hp babA
and babB (blood group antigen binding) adhesins and assess
any existing association between the status of these genes
and clinical outcomes in Iranian patients.
Methods: Hp virulence genes were ampliﬁed by means
of gene-speciﬁc polymerase chain reaction in clinical iso-
lates of Hp from 72 Iranian patients (16 GC, 12 PUD, 44 NUD
patients).
Results: Eleven categories of genotypes were
identiﬁed with the following frequencies: Group1:
A+B+/cagA+/s1(38.0%); Group2: A+B+/cag+/s2(2.8%);
Group3: A+B+/cag-/s1(1.4%); Group4: A+B-/cag+/s1(7%);
Group5: A+B-/cag+/s2(2.8%); Group6: A-B+/cag+/s1(22.5%);
Group7: A-B+/cag+/s2(14.1%); Group8: A-B+/cag-/s1(1.4%);
Group9: A-B+/cag-/s2(4.2%); Group10: A-B-/cag+/s1(2.8%);
Group11: A-B-/cag+/s2(2.8%). Frequency of Group1 in GC,
NUD and PUD patients is 75%, 27.3% and 27.3% respectively
and Group7 is prevalent in 36.4% of PUD patients. babA
prevalence in GC, NUD and PUD patients was 75%, 47.7%
and 33.3% and babB prevalence was 93.8%, 77.3% and 91.7%
respectively. 75% of Hp isolates were babA/babB double
positive in GC patients.
Conclusion: Frequency of babB is higher among Iranian GC
and PUD cases but babA frequency is limited to GC cases.
Infecting strains from Groups 1 and 7 were found to be asso-
ciated with GC and PUD respectively. Co-presence of cagA,
s1vacA, babA and babB may work synergistically in exacer-
bating the resulting inﬂammation which may create grounds
for development of intestinal metaplasia and eventually
GC, whereas co-existence of cagA, s2vacA, babB may cause
susceptibility to PUD development. In GC cases presence
of babA/babB double positive are signiﬁcantly prevalent
(p = 0.044). Application of this analysis on additional samples
will allow for a more concrete conclusion.
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Background: It is suggested that CD26 and CD30 are
surface molecules expressed on activated Th1 and Th2
cells, respectively. The aim of the present study was the
determination of the levels of soluble (s) CD26 and CD30
co-stimulatory molecules in sera of brucella-infected indi-
viduals. The correlations of sCD26 and sCD30 levels with
clinical presentation of the disease were assessed.
Methods: The study included 90 brucellosis patients (56
acute disease and 34 chronic form) and 70 healthy controls.
The levels of sCD26 and sCD30 were determined by a sand-
wich enzyme-linked immunosorbent assay in sera of study
population.
Results: The serum level of sCD26 and sCD30 were dif-
fered in patients with brucellosis. Stratiﬁcation of patients
according to disease status showed signiﬁcant higher levels
of sCD26 in the acute brucellosis compared to chronic dis-
ease and controls (P < 0.0001). The highest signiﬁcant levels
of sCD30 were shown in patients with chronic brucellosis
(P < 0.0001). However, the levels of sCD30 in two groups of
patients were more than healthy individuals.
Conclusion: These ﬁndings indicate that acute brucellosis
is driven by Th1 cells, while maintenance of chronic status is
associated with both Th1 and Th2-type responses. The sCD30
is more relevant to disease activity than sCD26 in patients
with brucellosis.
doi:10.1016/j.ijid.2008.05.532
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Objectives: At the present, cholera belongs to the group
of “reemerging” infections. V. cholerae non - O1 serotypes
non - agglutinating with polyvalent O1 antiserum are mainly
associated with sporadic cases of diarrhoeae and extrain-
testinal infections. Besides enterotoxin and endotoxin,
V.cholerae non- O1 can reveal other factors contributing
to the pathogenic potential of this species. The effects of
subinhibitory concentrations (sub - MICs) of enoxacin (EN),
ciproﬂoxacin (CIP), oﬂoxacin (OFL), norﬂoxacin (NOR) and
peﬂoxacin (PFL) on hydrophobicity, bioﬁlm formation, motil-
ity, enzymatic activities and response to oxidative stress
in two V. cholerae non - O1 strains (84/233,10/116) were
evaluated.
Methods: Adherence to xylene for hydrophobicity,
microtiter plate assay for bioﬁlm production, 0.35% agar for
motility, spectrophotometric methods for lipase and pro-
